Prudential Financial
AGIO icon

Prudential Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Prudential Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
9,955
+910
+10% +$27.6K ﹤0.01% 2022
2026
Q1 		$306K Sell
9,045
-72,010
-89% -$2.04M ﹤0.01% 2020
2025
Q4 		$2.21M Sell
81,055
-17,184
-17% -$603K ﹤0.01% 1267
2025
Q3 		$3.94M Sell
98,239
-60,120
-38% -$2.26M ﹤0.01% 1052
2025
Q2 		$5.27M Sell
158,359
-45,883
-22% -$1.39M 0.01% 881
2025
Q1 		$5.98M Buy
204,242
+99,320
+95% +$3.29M 0.01% 767
2024
Q4 		$3.45M Buy
104,922
+55,400
+112% +$2.6M ﹤0.01% 1022
2024
Q3 		$2.2M Sell
49,522
-58,330
-54% -$2.65M ﹤0.01% 1444
2024
Q2 		$4.65M Sell
107,852
-86,280
-44% -$3.11M 0.01% 956
2024
Q1 		$5.68M Buy
194,132
+124,600
+179% +$3.34M 0.01% 871
2023
Q4 		$1.55M Sell
69,532
-120
-0.2% -$2.69K ﹤0.01% 1596
2023
Q3 		$1.72M Sell
69,652
-43,200
-38% -$1.14M ﹤0.01% 1460
2023
Q2 		$3.2M Buy
+112,852
New +$2.81M ﹤0.01% 1144
2022
Q3 		– Sell
-55,858
Closed -$1.24M – 2647
2022
Q2 		$1.24M Buy
55,858
+42,200
+309% +$953K ﹤0.01% 1675
2022
Q1 		$397K Buy
13,658
+2,443
+22% +$74.6K ﹤0.01% 2300
2021
Q4 		$369K Sell
11,215
-8,882
-44% -$358K ﹤0.01% 2323
2021
Q3 		$927K Sell
20,097
-67,353
-77% -$3.25M ﹤0.01% 1842
2021
Q2 		$4.82M Buy
+87,450
New +$4.89M 0.01% 1039
2020
Q2 		– Sell
-30,108
Closed -$1.07M – 2393
2020
Q1 		$1.07M Sell
30,108
-600
-2% -$27.7K ﹤0.01% 1661
2019
Q4 		$1.47M Buy
+30,708
New +$1.16M ﹤0.01% 1729
2018
Q4 		– Sell
-2,610
Closed -$201K – 2376
2018
Q3 		$201K Buy
2,610
+100
+4% +$8.04K ﹤0.01% 2329
2018
Q2 		$211K Buy
+2,510
New +$219K ﹤0.01% 2331

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Prudential Financial's AGIO Position: Q2 2026 in Review

Prudential Financial increased its Agios Pharmaceuticals (AGIO) stake by 10% in Q2 2026, buying an estimated $27.6K and bringing the position to 9,955 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Prudential Financial first reported a position in AGIO in Q2 2018 and has held it in 22 quarters since. The position peaked at $5.98M in Q1 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Prudential Financial held 9,955 shares of Agios Pharmaceuticals worth $369K as of Q2 2026.
  • Prudential Financial bought 910 Agios Pharmaceuticals shares in Q2 2026, an estimated $27.6K.
  • Agios Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2022 holding.
  • Prudential Financial first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
  • Prudential Financial's Agios Pharmaceuticals position peaked at $5.98M in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.